USE OF SODIUM GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS IN THE CONTEXT OF TYPE 2 DIABETES MELLITUS.

Inhibitors of the sodium-glucose cotransporter type 2 (SGLT2i) belong to a relatively new pharmacological group, which are used in the treatment of type 2 diabetes mellitus. Diabetes mellitus is a noncommunicable chronic disease that according to the World Health Organization, has presented a significant increase in both its incidence and prevalence. Given this problem, a detailed analysis of the Inhibitors of the sodium-glucose cotransporter type 2 is presented, which are considered significantly by the scientific community due to their ability to avoid medical and renal complications. [ABSTRACT FROM AUTHOR]